Abstract
The X protein of hepatitis B virus (HBx) is one of the important factors in the development of hepatocellular carcinoma. Raf1 kinase is a central component of many signaling pathways that are involved in normal cell growth and oncogenic transformation. We previously demonstrated that hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity and that HBx and HBs might play an important role in this process. However, the underlying molecular mechanisms remain unclear. In this study, we show that nucleotides −209 to −133 of the Raf1 promoter sequence constitute the core region where hepatitis B virus is regulated. This regulation was found to require the involvement of cis-regulatory element AP-2α. We further demonstrated that AP-2α expression was higher in HepG2.2.15 cells (HBV-expressing cells) than in HepG2 cells in vitro. Silencing AP-2α expression by siRNA significantly inhibited the Raf1 promoter activity in HepG2.2.15 cells. These findings indicated that HBV regulates Raf1 promoter activity, possibly through AP-2α.
References
Halaban R (1994) Signal transduction in normal and malignant melant melanocytes. Pigment Cell Res 7(2):89–95
Yip-Schneider MT, Klein PJ, Wentz SC, Zeni A, Menze A, Schmidt CM (2009) Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. J Pharmacol Exp Ther 329(3):1063–1070
Eccles SA (2004) Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention. Int J Dev Bio 48(5–6):583–598
Kasid U, Dritschilo A (2003) RAF antisense oligonucleotide as a tumor radiosensitizer. Oncogene 22(37):5876–5884
Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, Yamamoto H, Fujimoto J, Okamoto E, Hayashi N, Hori M (1998) Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology 27(4):951–958
Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV (1997) Increased MAPK expression and activity in primary human hepatocellular carcinoma. Biochem Biophys Res Commun 236(1):54–58
Kalkuhl A, Troppmair J, Buchmann A, Stinchcombe S, Buenemann CL, Rapp UR, Kaestner K, Schwarz M (1998) p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions. Hepatology 27:1081–1088
Tian YY, Hu Y, Wang ZC, Chen K, Zhang L, Wang LY, Ren M, Huang AL, Tang H (2011) Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity. Arch Virol 156:869–874
Chen J, Siddiqui A (2007) Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J Virol 81(12):6757–6760
Calvisi DF, Ladu S, Gorden A et al (2006) Ubiquitous activation of Rasand Jak/Stat pathways in human HCC. Gastroenterology 130(4):1117–1128
Calvisi DF, Ladu S, Gorden A et al (2007) Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 117:2713–2722
Zhang XY, Zhang EJ, Ma ZY, Pei RJ, Jiang M, Schlaak Joerg F, Michael Roggendorf LuMJ (2011) Modulation of hepatitis B virus replication and hepatocyte differentiation by microRNA-1. Hepatology 53(5):1476–1485
Zhou Y, Wang S, Ma JW, Zhang L, Zhu HF, Lei P, Yang ZS, Zhang B, Yao XX, Shi C, Sun LF, Wu XW, Ning Q, Shen GX, Huang B (2010) Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-κB and increases migration of leukocytes. J Biol Chem 285(16):12159–12168
Keng VW, Tschida BR, Bell JB, Largaespada DA (2011) Modeling hepatitis B virus X–induced hepatocellular carcinoma in mice with the sleeping beauty transposon system. Hepatology 53(3):781–790
Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM (2001) Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J Biol Chem 276(37):34671–34680
Zhang L, Cai XF, Chen K, Wang ZC, Wang LY, Ren M, Huang AL, Tang H (2011) Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells. Virus Res 157:76–81
Liu QY, Chen JW, Liu L, Zhang J, Wang DF, Ma L, He YM, Liu YL, Liu ZS, Wu JG (2011) The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production. J Biol Chem 286(19):17168–17180
Jun HK, Hyune MR (2002) Activation of the human transforming growth factor alpha (TGF-α) gene by the hepatitis B viral X protein (HBx) through AP-2 sites. Mol Cell Biol 231:155–161
Seto E, Mitchell PJ, Yen TS (1990) Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72–74
Maguire HF, Hoeffler JP, Siddiqui A (1991) HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252(5007):842–844
Lu SC, Mato JM (2005) Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol associated liver cancer. Alcohol 35:227–234
Rajash P, Henry S, Chen JL, Hemant KP (2010) The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene. Gene 459:11–23
Alexander SK, Ulrich L, Ludwig W, Birgit L, Peter HH (1993) Hepatitis B Virus transactivator HBx uses a tumor promoter signaling pathway. Nature 361:742–745
Marriott SJ, Lee TH, Slagle BL, Butel JS (1996) Activation of the HTLV-I long terminal repeat by the hepatitis B virus X protein. Virology 224:206–213
Kannan P, Buettner R, Chiao PJ, Yim SO, Sarkiss M, Tainsky MA (1994) N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev 8:1258–1269
Narendra W, Kumaravel S (2003) Cell cycle arrest and apoptosis induction by activator protein 2α (AP-2α) and the role of p53 and p21WAF1/CIP1 in AP-2α mediated growth inhibition. J Biol Chem 278(52):52093–520101
Bar-Eli M (1999) Role of AP-2 in tumor growth and metastasis of human melanoma. Cancer Metastasis Rev 18:377–385
Leslie MC, Bar-Eli M (2005) Regulation of gene expression in melanoma: new approaches for treatment. J Cell Biochem 94:25–38
Narendra W, Chandrashekhar GR, Kumaravel S (2005) Activator protein 2α status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy. Cancer Res 65(19):8628–8634
Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M (2005) Loss of the AP-2α transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11:267–272
Vladislava OM, Andrey SD, Maya Z (2010) CREB inhibits AP-2α expression to regulate the malignant phenotype of melanoma. PLoS One 5:e12452
Orso F, Jäger R, Calogero RA, Schorle H, Sismondi P, De Bortoli M, Taverna D (2009) AP-2α regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase. BMC Biol 7:25
Orso F, Penna E, Cimino D, Astanina E, Maione F, Valdembri D, Giraudo E, Serini G, Sismondi P, De Bortoli M, Taverna D (2008) AP-2α and AP-2γ regulate tumor progression via specific genetic programs. FASEB J 22:2702–2714
Park MJ, Kwak HJ, Lee HC, Yoo DH, Park IC, Kim MS, Lee SH, Rhee CH, Hong SI (2007) Nerve growth factor induces endothelial cell invasion and cord formation by promoting matrix metalloproteinase-2 expression through the phosphatidylinositol 3-kinase/Akt signaling pathway and AP-2 transcription factor. J Biol Chem 282:30485–30496
Bosher JM, Williams T, Hurst HC (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92:744–747
Gilbertson RJ, Perry RH, Kelly PJ, Pearson AD, Lunec J (1997) Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res 57:3272–3280
Bennett KL, Romigh T, Eng C (2009) AP-2 induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma. PLoS One 4:e6931
Biadasiewicz K, Sonderegger S, Haslinger P, Haider S, Saleh L, Fiala C, Pollheimer J, Knöfler M (2011) Transcription factor AP-2 promotes EGF-dependent invasion of human trophoblast. Endocrinology 152(4):1458–1469
Acknowledgment
This work was supported by Nature Science Foundation of China (30771924) and Natural Science Foundation Project of CQ CSTC (2010BB5359). We thank Prof. Limin Chen of the Toronto General Research Institute, University of Toronto, for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
J. Qu and J. Li contributed equally to this work.
Rights and permissions
About this article
Cite this article
Qu, J., Li, J., Chen, K. et al. Hepatitis B virus regulation of Raf1 promoter activity through activation of transcription factor AP-2α. Arch Virol 158, 887–894 (2013). https://doi.org/10.1007/s00705-012-1561-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-012-1561-y